SCHEMBL7980109

SCHEMBL7980109

COc1ccc(-c2cccc(-c3nc(-c4ccsc4)c(NC(=O)c4ccccc4)o3)c2O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.44
ABCG2 Q9UNQ0 2/20 0.43
MAPT P10636 4/20 0.43
CCNE2 O96020 1/20 0.42
CCNE1 P24864 1/20 0.42
CDK2 P24941 1/20 0.42
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
ADORA3 P0DMS8 4/20 0.41
FLT1 P17948 2/20 0.41
ADORA1 P30542 2/20 0.41
KIT P10721 1/20 0.41
FLT4 P35916 1/20 0.41
NPSR1 Q6W5P4 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7986016 0.90 KDR (0.46) KDRMAPTADORA3FLT1ADORA1
SCHEMBL7980284 0.89 KDR (0.51) KDRMAPTCCNE2CCNE1CDK2
SCHEMBL7969458 0.88 KDR (0.46) KDRMAPTHSP90AA1HSP90AB1ADORA3
SCHEMBL7986529 0.88 KDR (0.44) KDRMAPTHSP90AA1FLT1KIT
SCHEMBL7982881 0.87 ADCY1 (0.50) KDRABCG2MAPTCCNE2CCNE1
SCHEMBL7969516 0.84 KDR (0.44) KDRABCG2MAPTADORA3FLT1
SCHEMBL7746570 0.79 KDR (0.49) KDRABCG2FLT1KITFLT4
SCHEMBL7982719 0.79 KDR (0.53) KDRMAPTCCNE2CCNE1CDK2
SCHEMBL7979692 0.79 KDR (0.54) KDRADORA3FLT1ADORA1FLT4
SCHEMBL7982851 0.78 KDR (0.52) KDRMAPTADORA3FLT1ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed